usdaed

Regeneron’s current star performer is a preparation called Dupixent, a rather ingenious concoction for soothing the woes of eczema sufferers. They share the spoils with Sanofi, which is always a civilized arrangement. It’s become quite the leader in its field, and they’re extending its talents to other bothersome conditions, including a particularly nasty form of lung trouble—Chronic Obstructive Pulmonary Disease, or COPD as the chaps in white coats call it—in the coming months.

The company beat expectations. Analysts, those who try to predict the whims of the market, had figured on something less. Less revenue, less profit. But DRS delivered. They spoke of strong demand for radars, for sensors that see in the dark. It’s a business built on seeing what others cannot, on preparing for shadows. The truth is, the world is a hungry place, and the appetite for security, for the illusion of control, is never sated.

BlackRock’s acquisition garnered the headlines, of course. Such grand gestures are always more palatable to the public imagination. But it is in the shadows, amongst the less celebrated ventures, that true opportunities often bloom. ValueAct’s move with Toast, while less dramatic, feels… considered. A recognition, perhaps, that even in an age of algorithms and automated kitchens, the simple act of nourishment remains stubbornly, beautifully, human.

The SEC filing of February 17, 2026, reveals this deliberate lessening of exposure to Frontier Group Holdings. It is a move not born of panic, one suspects, but of a pragmatic desire to refine the composition of their holdings. The reduction, while substantial in absolute terms, represents a mere fraction of their overall position, leaving them with a stake still valued at $16.88 million – a decrease of $2.03 million from the preceding quarter. One observes a certain restraint, a refusal to succumb to the more boisterous impulses that often grip the market.

So, after the closing bell Monday, a regulatory filing dropped – a document so thrilling, it’s a wonder it didn’t require a drumroll. Apparently, an entity associated with Mr. Sprott scooped up 150,000 shares. Not exactly a king’s ransom, but enough to make Hycroft’s stock price do a little jig. He now owns over 36.9 million shares. Thirty-six point nine million! I’ve got that many paperclips, and frankly, they’re not performing nearly as well.

Workiva (WK +0.19%)… honestly, the name. It sounds like a spa treatment. Anyway, the stock’s down 25% this year. And people are surprised? I’m not. It’s just… predictable. They aggregate data, create reports, regulatory filings… it’s all very… responsible. But responsible doesn’t pay the bills, does it? The idea that a manager is going to trust AI with something going to the SEC… it’s just… naive. One misplaced decimal point, a misspelled word, and suddenly you’re on the news. It’s a disaster waiting to happen. And it’s always the little things.

The fund, in the fourth quarter, decided it had seen enough of hand soaps and wallflowers. They sold it all. Not a share lingered. It’s a clean break, really. A decisive severing of ties. The market, of course, barely noticed. It rarely does, except when it’s convenient to notice.

Pershing Square, under Mr. Ackman’s direction, acquired 3.7 million shares. Egerton Capital, a further 1.8 million. The latter, I understand, now holds a substantial portion of its portfolio in the company. Baupost Group, ever cautious, added a little over 2.1 million. A respectable sum, certainly, though one wonders if they, too, are simply delaying the inevitable reckoning.

Seven million, five hundred and thirty thousand dollars. That was the estimated weight of this transaction, measured in the quarterly average of the share price. A tidy sum, easily lost and regained in the grand game. The books show it, of course. The Securities and Exchange Commission, a monument to paperwork and the illusion of control. But what does it mean? It means that someone believes the flow of data will only increase, that the hunger for bandwidth is insatiable. And they are likely correct. We build these networks not for ourselves, but for a future we scarcely understand, a future where every thought, every purchase, every fleeting glance is captured and commodified.

The numbers themselves are not precisely cause for jubilation. Revenue, at $66.7 million, represents a decline of 13% year on year. Net income, similarly, has withered by 22% to $30.7 million, or $1.06 per share. Adjusted Funds from Operations – the REIT’s preferred metric, and one which, naturally, presents a more favourable picture – fell by 16% to $53.3 million. One is reminded of a particularly disappointing herbaceous border.